The EDGE

Response as an end point in treatment trials for acute GVHD

S Z Pavletic

Bone Marrow Transplant 2012 47: 161-163; 10.1038/bmt.2011.59

Review

Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?

M E Bernardo, D Pagliara and F Locatelli

Bone Marrow Transplant 2012 47: 164-171; advance online publication, April 11, 2011; 10.1038/bmt.2011.81

Original Articles

HISTOCOMPATIBILITY AND DONOR SELECTION

What are a patient's current chances of finding a matched unrelated donor? Twenty years’ central search experience in a small country

A Rosenmayr, M Pointner-Prager, A Mitterschiffthaler, L Bozic, B Pelzmann, H Tüchler, I Fae, G F Fischer, H T Greinix, Ch Peters, P Kalhs, O Krieger, W Linkesch, D Nachbaur, Ch Urban, U Posch, G Lanzer, Ch Gabriel, H Schennach and W R Mayr

Bone Marrow Transplant 2012 47: 172-180; advance online publication, April 4, 2011; 10.1038/bmt.2011.67

CONDITIONING REGIMENS

Single center retrospective analysis of BU-based conditioning regimens in allogeneic transplantation

A M Wong, J C Allen, Y T Goh, Y C Linn, S M Y Loh, C P Diong, B Chowbay and W Y K Hwang

Bone Marrow Transplant 2012 47: 181-189; advance online publication, April 11, 2011; 10.1038/bmt.2011.43

Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT

M H ten Brink, J A Wessels, J den Hartigh, T van der Straaten, P A von dem Borne, H-J Guchelaar and J Zwaveling

Bone Marrow Transplant 2012 47: 190-195; advance online publication, March 28, 2011; 10.1038/bmt.2011.55

Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysis

M Hong, Q Wu, C Hu, J Fang, Y You, Z Zhong, P Zou, Y Hu and L Xia

Bone Marrow Transplant 2012 47: 196-202; advance online publication, March 28, 2011; 10.1038/bmt.2011.66

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

S M Luger, O Ringdén, M-J Zhang, W S Pérez, M R Bishop, M Bornhauser, C N Bredeson, M S Cairo, E A Copelan, R P Gale, S A Giralt, Z Gulbas, V Gupta, G A Hale, H M Lazarus, V A Lewis, M C Lill, P L McCarthy, D J Weisdorf and M A Pulsipher

Bone Marrow Transplant 2012 47: 203-211; advance online publication, March 28, 2011; 10.1038/bmt.2011.69

ALLOGRAFTING

Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

U Popat, M J de Lima, R M Saliba, P Anderlini, B S Andersson, A M Alousi, C Hosing, Y Nieto, S Parmar, I F Khouri, P Kebriaei, M Qazilbash, R E Champlin and S A Giralt

Bone Marrow Transplant 2012 47: 212-216; advance online publication, March 21, 2011; 10.1038/bmt.2011.61

Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation

S R Marino, S Lin, M Maiers, M Haagenson, S Spellman, J P Klein, T A Binkowski, S J Lee and K van Besien

Bone Marrow Transplant 2012 47: 217-226; advance online publication, March 28, 2011; 10.1038/bmt.2011.56

Allogeneic cellular gene therapy in hemoglobinopathies—evaluation of hematopoietic SCT in sickle cell anemia

G Lucarelli, J Gaziev, A Isgrò, P Sodani, K Paciaroni, C Alfieri, G De Angelis, M Marziali, M D Simone, C Gallucci, A Roveda, F Saltarelli, F Torelli and M Andreani

Bone Marrow Transplant 2012 47: 227-230; advance online publication, April 18, 2011; 10.1038/bmt.2011.79

AUTOGRAFTING

Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia

A Mahindra, B J Bolwell, L Rybicki, P Elder, M Kalaycio, R Dean, B Avalos, R Sobecks, S Tench, S Andresen, B Pohlman, J Sweetenham, S Devine and E Copelan

Bone Marrow Transplant 2012 47: 231-235; advance online publication, April 4, 2011; 10.1038/bmt.2011.73

MICROBIAL ISSUES

Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT

B Mohty, Y Thomas, M Vukicevic, M Nagy, E Levrat, M Bernimoulin, L Kaiser, E Roosnek, J Passweg and Y Chalandon

Bone Marrow Transplant 2012 47: 236-242; advance online publication, March 21, 2011; 10.1038/bmt.2011.57

In vitro activation of CMV-specific human CD8⁺ T cells by adenylate cyclase toxoids delivering pp65 epitopes

J Jelinek, I Adkins, Z Mikulkova, J Jagosova, R Pacasova, S Michlickova, P Sebo and J Michalek

Bone Marrow Transplant 2012 47: 243-250; advance online publication, March 28, 2011; 10.1038/bmt.2011.68

Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation

Z Peric, X Cahu, P Chevallier, E Brissot, F Malard, T Guillaume, J Delaunay, S Ayari, V Dubruille, S Le Gouill, B Mahé, T Gastinne, N Blin, B Saulquin, J-L Harousseau, P Moreau, M Coste-Burel, B-M Imbert-Marcille and M Mohty

Bone Marrow Transplant 2012 47: 251-257; advance online publication, March 28, 2011; 10.1038/bmt.2011.64

POST-TRANSPLANT EVENTS

Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD

J Sugita, T Matsushita, H Kashiwazaki, M Kosugi, S Takahashi, K Wakasa, S Shiratori, M Ibata, Y Shono, A Shigematsu, M Obara, K Fujimoto, T Endo, M Nishio, T Kondo, S Hashino, J Tanaka, M Asaka and M Imamura

Bone Marrow Transplant 2012 47: 258-264; advance online publication, March 21, 2011; 10.1038/bmt.2011.53

Long-term oral complications of allogeneic haematopoietic SCT

K M Hull, I Kerridge and M Schifter

Bone Marrow Transplant 2012 47: 265-270; advance online publication, March 28, 2011; 10.1038/bmt.2011.63

Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence

A Borgmann-Staudt, R Rendtorff, S Reinmuth, C Hohmann, T Keil, F R Schuster, W Holter, K Ehlert, P Keslova, A Lawitschka, A Jarisch and G Strauss

Bone Marrow Transplant 2012 47: 271-276; advance online publication, April 11, 2011; 10.1038/bmt.2011.78

GRAFT-VERSUS-HOST DISEASE

Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft

J Hasskarl, A Zerweck, R Wäsch, G Ihorst, H Bertz and J Finke

Bone Marrow Transplant 2012 47: 277-282; advance online publication, April 4, 2011; 10.1038/bmt.2011.45

QUALITY OF LIFE

Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): a report from the BMT Survivor Study

S H Armenian, C-L Sun, L Francisco, K S Baker, D J Weisdorf, S J Forman and S Bhatia

Bone Marrow Transplant 2012 47: 283-290; advance online publication, March 21, 2011; 10.1038/bmt.2011.60

Letters to the Editor

Aprepitant (Emend) significantly increases sirolimus levels in patients undergoing allogeneic hematopoietic SCT

S Shayani, J M Palmer, T Stiller, H Chan, S Keuylian, P Parker, S Thomas, V Pullarkat, A Nademanee, S J Forman and R Nakamura

Bone Marrow Transplant 2012 47: 291-293; advance online publication, March 7, 2011; 10.1038/bmt.2011.42

Cardiac tamponade potentially related to sirolimus following cord blood transplantation

A Holbro, I Ahmad, L Busque, S Cohen, S Lachance, D C Roy, J Roy, G Sauvageau and T Kiss

Bone Marrow Transplant 2012 47: 294-295; advance online publication, March 14, 2011; 10.1038/bmt.2011.44

Thyroid dysfunction in adult patients late after autologous and allogeneic blood and marrow transplantation

I Sánchez-Ortega, C Canals, T Peralta, R Parody, V Clapés, A F de Sevilla and R F Duarte

Bone Marrow Transplant 2012 47: 296-298; advance online publication, March 21, 2011; 10.1038/bmt.2011.54

Standardization of Aspergillus PCR diagnosis

J Loeffler, R Barnes and J P Donnelly on behalf of the European Aspergillus PCR Initiative

Bone Marrow Transplant 2012 47: 299-300; advance online publication, March 21, 2011; 10.1038/bmt.2011.58

Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMT

P Bories, E Zink, J F Mattern, O Villard, A Berceanu, K Bilger, E Candolfi, R Herbrecht, A Abou-Bacar and B Lioure

Bone Marrow Transplant 2012 47: 301-303; advance online publication, March 21, 2011; 10.1038/bmt.2011.62

Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors

S Saußele, R Hehlmann, A Gratwohl and A Hochhaus

Bone Marrow Transplant 2012 47: 304; advance online publication, March 28, 2011; 10.1038/bmt.2011.70

Immunological reconstitution in a patient with ZAP-70 deficiency following transfusion of blood lymphocytes from a previously transplanted sibling without conditioning

M Hönig, C Schuetz, K Schwarz, M Rojewski, E Jacobsen, G Lahr, K-M Debatin, A Schulz and W Friedrich

Bone Marrow Transplant 2012 47: 305-307; advance online publication, March 28, 2011; 10.1038/bmt.2011.71

Pulmonary micro-embolism in a healthy donor following G-CSF administration for mobilization of hemopoietic progenitor cells

M Martino, E Massara, G Irrera, G Messina, G Barreca and G Console

Bone Marrow Transplant 2012 47: 308-310; advance online publication, April 4, 2011; 10.1038/bmt.2011.72

BU, melphalan and thiotepa as a preparative regimen for auto-transplantation in Hodgkin’s disease

S Ganguly, V Jain, C Divine, O Aljitawi, S Abhyankar and J McGuirk

Bone Marrow Transplant 2012 47: 311-312; advance online publication, April 4, 2011; 10.1038/bmt.2011.74

Fertility preservation in young patients before allogeneic haematopoietic SCT

L Bastings, J R Westphal, C C M Beerendonk, D D M Braat and R Peek

Bone Marrow Transplant 2012 47: 313-314; advance online publication, November 28, 2011; 10.1038/bmt.2011.235

Deferasirox increases BU blood concentrations

K Sweiss, P Patel and D Rondelli

Bone Marrow Transplant 2012 47: 315-316; advance online publication, April 4, 2011; 10.1038/bmt.2011.75

DRESS or ‘picture of DRESS’

V Descamps

Bone Marrow Transplant 2012 47: 317; advance online publication, April 4, 2011; 10.1038/bmt.2011.76

CMV encephalitis in BMT recipients

H Sarva, J Graber, R Remanan, M Rosenblum and A Omuro

Bone Marrow Transplant 2012 47: 318-320; advance online publication, April 4, 2011; 10.1038/bmt.2011.80